25th Nov 2008 11:36
SKYEPHARMA TO PRESENT AT PIPER JAFFRAY
2008 HEALTH CARE CONFERENCE
LONDON, UK, 25 November 2008 -- SkyePharma PLC (LSE: SKP) announces today that the Company's Chief Executive Officer, Dr Ken Cunningham, and Chief Financial Officer, Peter Grant, will participate in the Piper Jaffray 2008 Health Care Conference in New York. Dr Cunningham's "fireside chat" will take place at 2.30 pm EST (7.30 pm GMT) on Wednesday 3 December 2008. The webcast may be accessed at http://www.skyepharma.com/investor-relations/presentations.html or http://www.piperjaffray.com/conferences. An archived version of the webcast will be available shortly thereafter. Please note that due to the new format of this year's Piper Jaffray conference there will be no slides available.
For further information please contact:
|
SkyePharma PLC |
Ken Cunningham |
+44 20 7491 1777 |
|
During office hours |
Peter Grant |
|
|
Financial Dynamics (UK Enquiries) |
David Yates |
+44 20 7831 3113 |
|
Outside office hours |
Jonathan Birt |
|
|
Trout Group (US Enquiries) |
Seth Lewis |
+1 617 583 1308 |
|
Brandon Lewis |
About SkyePharma PLC
Using its proprietary drug delivery technologies, SkyePharma develops new formulations of existing products to provide a clinical advantage and life-cycle extension. The Company has twelve approved products in the areas of oral, inhalation and topical delivery. The Group's products are marketed throughout the world by leading pharmaceutical companies. For more information, visit www.skyepharma.com.
Related Shares:
SKP.L